In the high-stakes world of life sciences, effectively communicating scientific breakthroughs is just as critical as the discoveries themselves. However, the stringent need for accuracy and academic rigor has traditionally made medical communications (MedComms) a slow and costly process, often requiring the intervention of specialized agencies. Now, a newly reimagined AI-native platform, Prezent Vivo 1.0, is stepping in to solve this industry-wide bottleneck.

While the explosive rise of generative AI has accelerated content creation across various industries, its lack of reliable accuracy has severely hindered its adoption in life sciences. Prezent Vivo 1.0 addresses this exact pain point by blending artificial intelligence with human accountability.

Imagen via: Prezent

Trusted by more than 150 life sciences companies—including 45 of the world’s top 50 BioPharma organizations—the platform allows Medical Affairs and Commercial teams to produce high-quality communications rapidly and cost-effectively without compromising scientific integrity.

At the heart of this major update is an interactive content studio that integrates seamlessly with over 25 enterprise and scientific data sources, such as PubMed, Veeva, and Microsoft Copilot. The system is powered by “Astrid,” Prezent’s specialized AI agent. While teams experiment with visuals and drafts, Astrid works behind the scenes to ensure that brand compliance, regulatory terminology, and clinical evidence structures are deeply embedded into the very first draft.

A standout feature for the vital conference season is Astrid’s ability to instantly generate publication-quality scientific posters. By ingesting abstracts, clinical study reports, publications, and spreadsheets, the AI can autonomously produce congress-ready visuals in mere minutes, empowering teams to work more independently.

Recognizing that software alone isn’t a silver bullet for high-stakes projects, Prezent Vivo 1.0 introduces a flexible service model that bridges the gap between automation and expert oversight.

“Prezent Vivo 1.0 gives Life Sciences teams the flexibility to work the way they need, with AI, experts, or a combination of both, helping them reduce costs without compromising scientific quality,” explained Francine Carrick, President of Prezent Vivo.

To achieve this, the platform has launched “Fixed-Price Projects,” a fully managed service that delivers agency-quality work in 24 to 72 hours at a cost reduction of over 50% compared to traditional models. This suite covers Competitive Intelligence 360, AdBoard Insights for advisory board meetings, and 72-hour poster deliveries for accepted abstracts. For projects requiring even closer attention, the company provides overnight editorial services staffed by dedicated subject matter experts.

Ultimately, the goal is to streamline the entire MedComms workflow into a single, unified ecosystem. As Prezent CEO and Co-Founder Rajat Mishra noted, “Scientific breakthroughs only matter when they’re communicated effectively. Prezent Vivo 1.0 brings AI and human expertise together to help Life Sciences teams move from discovery to better patient outcomes, faster”